<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">296</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2009-0-1-2-76-80</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. DIAGNOSIS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. ДИАГНОСТИКА</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">STATISTICS OF GYNECOLOGICAL MALIGNANCIES</article-title><trans-title-group xml:lang="ru"><trans-title>СТАТИСТИКА ЗЛОКАЧЕСТВЕННЫХ НОВООБРАЗОВАНИЙ ЖЕНСКИХ ПОЛОВЫХ ОРГАНОВ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aksel</surname><given-names>Ye. M.</given-names></name><name xml:lang="ru"><surname>Аксель</surname><given-names>Е. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow</institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-05-01" publication-format="electronic"><day>01</day><month>05</month><year>2009</year></pub-date><issue>1-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>76</fpage><lpage>80</lpage><history><date date-type="received" iso-8601-date="2014-09-03"><day>03</day><month>09</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-09-03"><day>03</day><month>09</month><year>2014</year></date></history><permissions><copyright-year>2009</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/296">https://ojrs.abvpress.ru/ojrs/article/view/296</self-uri><abstract xml:lang="en"><p>The paper analyzes data on the state-of-the-art of oncological care given to patients with gynecological cancer, considers differences in morbidity rates between individual population groups and regions, and compares the maximum and minimum cancer morbidity rates among different populations.</p></abstract><trans-abstract xml:lang="ru"><p>Успех борьбы со злокачественными новообразованиями определяется наличием и возможностью реализации научно обоснованной нацио- нальной противораковой программы, направленной на снижение заболеваемости, смертности и повышение продолжительности жизни больных. Различия в уровнях заболеваемости между отдельными группами населения и регионами служат основой не только для выявле- ния предполагаемых факторов риска, но и для определения теоретических возможностей профилактики заболевания. В статье предста- влены данные по соответствующим показателям заболеваемости и смертности населения России при злокачественных новообразовани- ях женских половых органов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>morbidity</kwd><kwd>mortality</kwd><kwd>prevention</kwd><kwd>cancer of the cervix uteri</kwd><kwd>cancer of the corpus uteri</kwd><kwd>ovarian cancer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>заболеваемость</kwd><kwd>смертность</kwd><kwd>профилактика</kwd><kwd>рак шейки матки</kwd><kwd>рак тела матки</kwd><kwd>рак яичников</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Cancer in Finland 2002 and 2003. Cancer Society of Finland. Helsinki, 2005.</mixed-citation><mixed-citation xml:lang="ru">Cancer in Finland 2002 and 2003. Cancer Society of Finland. Helsinki, 2005.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Ferlay J., Bray F., Pissani P., Parkin D.M. Globocan 2002: cancer incidence, mortality and prevalence worldwide IARC CancerBase No5, version 2.0. IARC Press, Lyon, 2004.</mixed-citation><mixed-citation xml:lang="ru">Ferlay J., Bray F., Pissani P., Parkin D.M. Globocan 2002: cancer incidence, mortality and prevalence worldwide IARC CancerBase No5, version 2.0. IARC Press, Lyon, 2004.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Jemal D., Siegel M., Ward D. et al. Cancer Statistics, 2006. Ca Cancer J Clin 2006;56:106—30.</mixed-citation><mixed-citation xml:lang="ru">Jemal D., Siegel M., Ward D. et al. Cancer Statistics, 2006. Ca Cancer J Clin 2006;56:106—30.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
